Quick Answer
Vaxart, Inc. reported Total Assets of $186.08 million for fiscal year 2025.
Vaxart, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $186.08M | +11.8% |
| 2024 | $166.39M | +81.2% |
| 2023 | $91.83M | -40.3% |
| 2022 | $153.85M | -30.4% |
| 2021 | $221.17M | +45.0% |
| 2020 | $152.58M | +312.0% |
| 2019 | $37.03M | +5.1% |
| 2018 | $35.23M | +678.8% |
| 2017 | $4.52M | -88.7% |
| 2017 | $40.10M | -44.8% |
| 2016 | $72.70M | -8.4% |
| 2015 | $79.40M | -30.4% |
| 2014 | $114.00M | +32.9% |
| 2013 | $85.80M | +23.8% |
| 2012 | $69.30M | -29.3% |
| 2011 | $97.97M | -14.0% |
| 2010 | $113.87M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $208.99M | +25.4% | +27.4% |
| June 30, 2025 | $164.09M | +44.3% | +3.5% |
| March 31, 2025 | $158.56M | +78.8% | -4.7% |
| December 31, 2024 | $166.39M | +81.2% | -0.2% |
| September 30, 2024 | $166.67M | +57.8% | +46.5% |
| June 30, 2024 | $113.75M | -7.3% | +28.3% |
| March 31, 2024 | $88.67M | — | -3.4% |
| December 31, 2023 | $91.83M | -40.3% | -13.1% |
- Vaxart, Inc. showed an increase of +11.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Vaxart, Inc.’s total assets has grown by 63.4% (from $113.87 million to $186.08 million).
- The most recent figure is from Vaxart, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: